Lipedema denials in California external review

In the California DMHC record, independent physician reviewers decided 53 published external-review cases involving lipedemaand overturned the plan’s denial in 39.6%. That is a historical result among cases that reached this program, not a forecast for an individual appeal.

California DMHC decisions
53
2004–2026
Overturned
39.6%
21 denials reversed

Most-fought treatments for lipedema

What insurers denied — and how those fights ended.
CategoryDecisionsOverturned
Liposuction11
9.1%
Suction Assisted Lipectomy6
50%
Typical time to a decision
14 days
Most land between 6 and 21 days
Handled as urgent
41.5%
Expedited when a delay would cause harm
Recent direction
Rising
36.8%43.8% overturned, last three years

What the reviewers wrote

Excerpts from the independent reviewers’ published findings — the actual reasoning, quoted, not summarised.

Where the denial was overturned

Findings: The physician reviewer found that Nature of Statutory Criteria/Case Summary: The patient has requested authorization and coverage for suction assisted lipectomy of the bilateral arms and bilateral legs with associated hospitalization.Researchers report that lipedema is believed to affect 11% to 39% of the female Caucasian population worldwide, and that as many as 16 million women in the United States may be affected with the disorder. Researchers state, “Lipedema is an uncommon disorder characterized by localized adiposity of the lower extremities, often occurring in females with a family history of the condition. The adiposity extends from hips to ankles and is typically unresponsive to weight loss. In addition to the aesthetic deformity, women also describe pain in the lower extremities, particularly with pressure, as well as easy bruising.
Medical Necessity · 2023 · IMR MN23-39962
Nature of Statutory Criteria/Case Summary: The patient has requested authorization and coverage for suction assisted protein lipectomy (SAPL). Reich-Schupke and colleagues state, “The diagnosis [of lipedema] is established on the basis of medical history and clinical findings. Characteristically, there is a localized, symmetrical increase in subcutaneous adipose tissue in arms and legs that is in marked disproportion to the trunk. Other findings include edema, easy bruising, and increased tenderness. Further diagnostic tests are usually reserved for special cases that require additional workup.
Medical Necessity · 2020 · IMR MN20-34490

Where the denial was upheld

Worth reading too — these show what an appeal has to overcome.
Nature of Statutory Criteria/Case Summary: The patient has requested authorization and coverage for (1) bilateral lymph sparing liposuction to upper and lower extremities and trunk and (2) excision of excessive skin/subcutaneous tissue to bilateral thigh, legs, arms and trunk. Warren Peled and Kappos state, “Lipedema is an uncommon disorder characterized by localized adiposity of the lower extremities, often occurring in females with a family history of the condition. The adiposity extends from hips to ankles and is typically unresponsive to weight loss. In addition to the aesthetic deformity, women also describe pain in the lower extremities, particularly with pressure, as well as easy bruising.
Medical Necessity · 2021 · IMR MN21-34729
Findings: The physician reviewer found that Nature of Statutory Criteria/Case Summary: The patient requested authorization and coverage for lipedema and panniculectomy surgeries.The authors of a study stated that lipedema is an uncommon disorder characterized by localized adiposity of the lower extremities, often occurring in females with a family history of the condition. The adiposity extends from hips to ankles and is typically unresponsive to weight loss. In addition to the aesthetic deformity, patients also describe pain in the lower extremities, particularly with pressure, as well as easy bruising. One of the major distinguishing features of lipedema is the sparing of the feet, which can create a distinct step-off at the ankle.
Medical Necessity · 2024 · IMR MN24-42229

Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California external-review outcomes. Other state and federal programs have different eligibility rules, processes, and current availability; the rates here do not transfer to those programs or predict an individual result. Excerpts are quoted verbatim from the public record and describe this condition generally, not any individual case.

How to use this in your appeal

These outcomes describe eligible cases completed through California DMHC’s Independent Medical Review program. They do not estimate the chance that an internal appeal, an external review in another jurisdiction, or your individual case will succeed. Use the record to identify evidence patterns involving lipedema, then check the rights and deadlines that apply to your plan.

SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · AGGREGATES + DEIDENTIFIED DECISION EXCERPTS/REFERENCE IDS · METHODOLOGY

Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.

Fighting a denial for lipedema? Use the California record to prepare.

Explain my denial — freeStart my appeal · $39